Compared with those in healthy donors, HMGB1 levels have been reported to be increased in the serum and skin lesions of patients with psoriasis vulgaris (PV), and while serum HMGB1 levels significantly increase with disease progression, they are downregulated after standard therapies are given (44, 45). This evidence concerns the gene HMGB1 and psoriasis vulgaris.